Literature DB >> 20938632

[Psycho-oncology - psychosocial oncology: integration in a concept of oncological treatment].

B Sperner-Unterweger1.   

Abstract

Psycho-oncology is defined by psychosocial aspects of prevention, etiology, diagnostics, treatment, and rehabilitation of cancer. It is characterized by interdisciplinary medicine, as well as cooperation between medical and nonmedical professionals. Psychosocial distress and/or psychiatric disorders are manifested in 30-60% of cancer patients. The primary target of psycho-oncological management is to retain and ideally optimize the subjective quality of life of cancer patients. It is important to understand that psycho-oncological care is part of an integrative oncological patient management. Basic psycho-oncological management is usually provided by the primary oncologist, whereas more specific psycho-oncological measures call for specially trained psychiatric/psychotherapeutic staff. Psycho-oncological interventions include psychological/psychotherapeutic, as well as psychopharmacologic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20938632     DOI: 10.1007/s00115-010-3163-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  14 in total

1.  History of psycho-oncology: overcoming attitudinal and conceptual barriers.

Authors:  Jimmie C Holland
Journal:  Psychosom Med       Date:  2002 Mar-Apr       Impact factor: 4.312

Review 2.  Psychosocial interventions for cancer: review and analysis using a three-tiered outcomes model.

Authors:  J E Owen; J C Klapow; B Hicken; D C Tucker
Journal:  Psychooncology       Date:  2001 May-Jun       Impact factor: 3.894

Review 3.  Social cognitive theory and cancer patients' quality of life: a meta-analysis of psychosocial intervention components.

Authors:  Kristi D Graves
Journal:  Health Psychol       Date:  2003-03       Impact factor: 4.267

4.  The prevalence of psychological distress by cancer site.

Authors:  J Zabora; K BrintzenhofeSzoc; B Curbow; C Hooker; S Piantadosi
Journal:  Psychooncology       Date:  2001 Jan-Feb       Impact factor: 3.894

Review 5.  [Incidence, pathoetiology and treatment of interferon-alpha induced neuro-psychiatric side effects].

Authors:  M Schäfer; M Schwaiger
Journal:  Fortschr Neurol Psychiatr       Date:  2003-09       Impact factor: 0.752

6.  The prevalence of psychiatric disorders among cancer patients.

Authors:  L R Derogatis; G R Morrow; J Fetting; D Penman; S Piasetsky; A M Schmale; M Henrichs; C L Carnicke
Journal:  JAMA       Date:  1983-02-11       Impact factor: 56.272

Review 7.  Identifying patients at risk for, and treatment of major psychiatric complications of cancer.

Authors:  W Breitbart
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

8.  Psychologic intervention improves survival for breast cancer patients: a randomized clinical trial.

Authors:  Barbara L Andersen; Hae-Chung Yang; William B Farrar; Deanna M Golden-Kreutz; Charles F Emery; Lisa M Thornton; Donn C Young; William E Carson
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

Review 9.  Psychological interventions for women with metastatic breast cancer.

Authors:  Adrian Gk Edwards; Nicholas Hulbert-Williams; Richard D Neal
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

Review 10.  [Depressive disorders with somatic illnesses].

Authors:  V Arolt; M Rothermundt
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

View more
  2 in total

1.  [Psychiatric psychotherapeutic interventions in breast cancer inpatients: a contribution to liaison-consultation psychiatry].

Authors:  M Grube; H Weigand-Tomiuk
Journal:  Nervenarzt       Date:  2014-11       Impact factor: 1.214

2.  Supporting Medical Staff from Psycho-Oncology with Smart Mobile Devices: Insights into the Development Process and First Results.

Authors:  Johannes Schobel; Madeleine Volz; Katharina Hörner; Peter Kuhn; Franz Jobst; Julian D Schwab; Nensi Ikonomi; Silke D Werle; Axel Fürstberger; Klaus Hoenig; Hans A Kestler
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.